ArticleCancer chemotherapy and pharmacology2023

Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis.

Arunima Jaiswal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.